Carole L. Wallis
Carole L. Wallis publishes mostly in Infectious Diseases, Virology and Epidemiology, on topics such as HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions and HIV Research and Treatment.
- World rank
- #874,529 of 7,710,434 ranked researchers
- Rank in South Africa
- #3,436 of 29,826
- Works
- 143
- Citations
- 4.3k
- Citations per work
- 30.3
What does Carole L. Wallis research?
Carole L. Wallis's work is mostly in Medicine (59%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8962.1%
- Medicine8559.1%
- Health Professions43.0%
- Life Sciences3020.8%
- Everything else2417.1%
- 1Infectious Diseases46% of their works
- 2Virology17% of their works
- 3Epidemiology8% of their works
- 4Emergency Medicine4% of their works
- 5Molecular Biology4% of their works
- 6General Health Professions3% of their works
Research topics
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- HIV Research and Treatment
- HIV-related health complications and treatments
- Tuberculosis Research and Epidemiology
- HIV, Drug Use, Sexual Risk
- Biological Research and Disease Studies
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Carole L. Wallis's research?
The keywords of their largest research topics: Antiretroviral Therapy, HIV Infection, Drug Resistance, Integrase Inhibitors, Nucleoside Analogues, HIV, Immune Response and Vaccine.
- Pneumocystis
- Phosphoethanolamine
- drug use
- Mycobacterium tuberculosis
- Cardiovascular Disease
- Diagnosis
- Antibodies
- Preexposure Prophylaxis
- Vaccine
- HIV
- Integrase Inhibitors
- HIV Infection
- Antiretroviral Therapy
- Drug Resistance
- Nucleoside Analogues
- Immune Response
- HIV Transmission
- AIDS
- Epidemiology
- Treatment
- Inflammation
- Tuberculosis
- harm reduction
- Synthetic
- Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Antiretroviral Therapy2555 topics
- HIV Infection1032 topics
- Drug Resistance992 topics
- Integrase Inhibitors861 topic
- Nucleoside Analogues861 topic
- HIV853 topics
- Immune Response822 topics
- Vaccine822 topics
- HIV Transmission761 topic
- Preexposure Prophylaxis761 topic
- AIDS691 topic
- Antibodies691 topic
- Epidemiology293 topics
- Diagnosis202 topics
- Treatment202 topics
- Cardiovascular Disease171 topic
- Inflammation171 topic
- Mycobacterium tuberculosis131 topic
- Tuberculosis131 topic
- drug use91 topic
- harm reduction91 topic
- Phosphoethanolamine81 topic
- Synthetic81 topic
- Pneumocystis71 topic
- Pneumonia71 topic
Where does Carole L. Wallis work?
Carole L. Wallis's main affiliation in the publication record is Lancet Laboratories, South Africa.
How many publications and citations does Carole L. Wallis have?
OpenAlex counts 143 works and 4,340 citations for Carole L. Wallis, an h-index of 37, ranking #874,529 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carole L. Wallis. Posts are plain text and can be reported.